• Skip to primary navigation
  • Skip to content
  • Skip to footer
Genelex Logo

Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
    • Patient Stories
  • Providers
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • News
    • Contact Us
  • Log In

Genelex executive to speak on 2015 SXSW discussion panel

Home / News / Genelex executive to speak on 2015 SXSW discussion panel

Genelex Blog

Genelex executive to speak on 2015 SXSW discussion panel

SXSWGenelex will have a face at this year’s SXSW Interactive Festival, one of the world’s most well-known global technology conferences, in Austin, Texas, on March 16.

Kristine Ashcraft, Genelex’s Chief Operation Officer, will be part of a four-person panel discussion titled “Personalized Medicine: From a Vision Into a Plan”. The hour-long discussion will focus on how long it might take for the vision of personalized medicine to become a reality.

“They say it takes 17 years for medical research to make it to the patient; this is unacceptable, and we have the tools to shorten this timeline, especially in personalized medicine,” said Ashcraft, who joined Genelex in 2000.

“SXSW is known for attracting innovators that are pushing the envelope in many areas, and I am honored to speak and meet people that are interested in shortening the adoption curve.”

Ashcraft will join three other health care professionals in the field of personalized medicine on the discussion panel. The SXSW Interactive Festival is part of the larger, three-part SXSW conference, which also includes music and film festivals. Last year, more than 32,000 people attended the Interactive Conference alone.

Learn more about the conference and how to register here. Also, be sure to keep up with the personalized medicine discussion on Twitter by searching the hashtags #SXSW and #PersMed.

Talk of personalized medicine has received a boost recently after President Barack Obama’s State of the Union address, in which he called for a “precision medicine” initiative. The President made it clear that it is necessary and expedient to use modern technology to provide personalized treatment for all Americans, not just those suffering from complex diseases.

Genelex is proud to be leader in personalized medicine through its innovations in pharmacogenetic testing and analysis. Our YouScript Personalized Prescribing System pairs pharmacogenetic testing with the most comprehensive medication management software available.

Genelex Resources

Affected Conditions
Affected Drugs
Info for Providers
Frequently Asked Questions
Contact Genelex
Join Our Mailing List
ORDER A TEST

Take a Risk Assessment

Simply enter the medications you’re currently on or plan to take. Click “Get Results” to see if your regimen puts you at risk for an adverse drug reaction.

YOUR GENELEX RISK ASSESSMENT RESULTS:

Reader Interactions

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
Resources
FAQs

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Testimonials

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.

© GENELEX 2019 ・ PRIVACY POLICY ・ REFERENCES ・ CAP LAB 4344001 ・CLIA 50D0980559 ・NYDOH PFI 8201